NCT01404390View on ClinicalTrials.gov

Japanese BAY80-6946 Monotherapy Phase I Study

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

August 18, 2011

Primary Completion Date

March 22, 2012

Study Completion Date

July 12, 2012

Conditions
Neoplasms
Interventions
DRUG

BAY80-6946

0.4mg/ kg, iv, day 1,8 and 15, every 28 days

DRUG

BAY80-6946

0.8mg/ kg, iv, day 1,8 and 15, every 28 days

Trial Locations (1)

277-8577

Kashiwa

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY